Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Joanna Grycewicz"'
Autor:
Katarzyna Cypryk, Joanna Grycewicz, Patrycja Swierzewska, Marcin Kosinski, Andrzej Lewinski, Monika Zurawska-Klis
Publikováno v:
Annals of Agricultural and Environmental Medicine, Vol 25, Iss 1, Pp 114-119 (2018)
Introduction The problem concerning the impact of pregnancy on diabetic complications is a matter for discussion as there is some evidence suggesting that pregnancy may trigger development or progression of diabetic chronic complications. However, cu
Externí odkaz:
https://doaj.org/article/48c4199c920445ed8184b4034b06c479
Publikováno v:
Archives of Medical Science : AMS
Hypoglycaemia is the most frequent acute complication of diabetes, regardless of the type of diabetes and the treatment method. Hormonally active tumours of the pancreas, insulinomas, which belong to digestive tract neuroendocrine tumours, constitute
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66d75040fac2dc82e29b25599af19b9c
https://doi.org/10.5114/aoms.2010.13520
https://doi.org/10.5114/aoms.2010.13520
Autor:
Maciej Banach, Robert Irzmański, Lucjan Pawlicki, Joanna Grycewicz, Marcin Barylski, Jan Kowalski
Publikováno v:
Journal of cardiovascular pharmacology. 48(4)
Neutrophil superoxide anion generation was measured during atorvastatin and fluvastatin therapy in patients with coronary heart disease (CHD) risk. The patients were randomly allotted into three groups. The atorvastatin group comprised 17 patients wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97a0fb8e65175b614a348c84c84ed012
https://pubmed.ncbi.nlm.nih.gov/17086091
https://pubmed.ncbi.nlm.nih.gov/17086091
Autor:
Jan, Kowalski, Lucjan, Pawlicki, Joanna, Grycewicz, Jan, Błaszczyk, Robert, Irzmański, Tomasz, Cegliński, Edward, Kowalczyk, Beata, Liban-Gałka
Publikováno v:
Wiadomosci lekarskie (Warsaw, Poland : 1960). 58(7-8)
The study comprised 35 patients with mixed hyperlipidaemia and coronary heart disease (CHD) risk factors (overweight or obesity, low physical activity, family history). Seventeen patients were administered atorvastatin in a dose of 10 mg and 18 -fluv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8805f3419ad3454a7c4ad7fbdf363031
https://pubmed.ncbi.nlm.nih.gov/16425789
https://pubmed.ncbi.nlm.nih.gov/16425789
Autor:
Jan, Kowalski, Lucjan, Pawlicki, Joanna, Grycewicz, Jan, Błaszczyk, Robert, Irzmańiski, Tomasz, Ceglińiski, Edward, Kowalczyk, Beata, Liban-Gałka
Publikováno v:
Wiadomosci lekarskie (Warsaw, Poland : 1960). 58(5-6)
The effect of atorvastatin and fluvastatin on antioxidative enzymatic activity was studied in CHD risk patients. The study comprised 35 patients (20 men and 15 women) aged 35-47 years, who were allotted into two groups: I--18 patients were administer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8021917a93544fb4735a26cf8815bbbf
https://pubmed.ncbi.nlm.nih.gov/16238116
https://pubmed.ncbi.nlm.nih.gov/16238116
Autor:
Robert Irzmański, Jan Kowalski, Edward Kowalczyk, Lucjan Pawlicki, Jan Błaszczyk, Tomasz Cegliński, Joanna Grycewicz
Publikováno v:
Fundamentalclinical pharmacology. 18(1)
We estimated the effect of atorvastatin and fluvastatin on plasma antioxidative activity used in coronary heart disease (CHD) primary prevention. Anti-oxidative activity of blood plasma was determined by Bartosz et al. method [Curr. Top. Biophys. (19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d71914900d05531f8cf60273fffb6169
https://pubmed.ncbi.nlm.nih.gov/14748760
https://pubmed.ncbi.nlm.nih.gov/14748760